Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

(2010) A. Jaccard et al.   BLOOD

Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma

(2009) Y.-X. Li et al.   CLINICAL CANCER RESEARCH

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

(2009) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

(2009) Seok Jin Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009

(2009) Yok-Lam Kwong et al.   LANCET ONCOLOGY

L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type

(2008) Weiben Yong et al.   ANNALS OF HEMATOLOGY

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

(2008) T. M. Kim et al.   ANNALS OF ONCOLOGY

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

(2008) W.-y. Au et al.   BLOOD

Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract

(2007) Mei-juan Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS